777 related articles for article (PubMed ID: 15808355)
1. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
2. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
3. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
5. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
Festoff BW; Sajja RK; van Dreden P; Cucullo L
J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
9. Neurovascular pathways and Alzheimer amyloid beta-peptide.
Zlokovic BV; Deane R; Sallstrom J; Chow N; Miano JM
Brain Pathol; 2005 Jan; 15(1):78-83. PubMed ID: 15779240
[TBL] [Abstract][Full Text] [Related]
10. The pericyte: a forgotten cell type with important implications for Alzheimer's disease?
Winkler EA; Sagare AP; Zlokovic BV
Brain Pathol; 2014 Jul; 24(4):371-86. PubMed ID: 24946075
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
12. The role of perivascular innervation and neurally mediated vasoreactivity in the pathophysiology of Alzheimer's disease.
Nizari S; Romero IA; Hawkes CA
Clin Sci (Lond); 2017 Jun; 131(12):1207-1214. PubMed ID: 28566449
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.
Salmina AB; Kharitonova EV; Gorina YV; Teplyashina EA; Malinovskaya NA; Khilazheva ED; Mosyagina AI; Morgun AV; Shuvaev AN; Salmin VV; Lopatina OL; Komleva YK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925080
[TBL] [Abstract][Full Text] [Related]
14. Targeting the neurovascular unit: development of a new model and consideration for novel strategy for Alzheimer's disease.
Liu R; Zhang TT; Wu CX; Lan X; Du GH
Brain Res Bull; 2011 Aug; 86(1-2):13-21. PubMed ID: 21700401
[TBL] [Abstract][Full Text] [Related]
15. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide.
Pluta R; Jabłoński M; Czuczwar SJ
Folia Neuropathol; 2012; 50(2):101-9. PubMed ID: 22773455
[TBL] [Abstract][Full Text] [Related]
16. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
Janota C; Lemere CA; Brito MA
Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
[TBL] [Abstract][Full Text] [Related]
18. Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.
ElAli A; Thériault P; Préfontaine P; Rivest S
Acta Neuropathol Commun; 2013 Nov; 1():75. PubMed ID: 24252187
[TBL] [Abstract][Full Text] [Related]
19. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
20. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
